NCT06505551 2024-07-17
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
SCG Cell Therapy Pte. Ltd.
Phase 1/2 Not yet recruiting
SCG Cell Therapy Pte. Ltd.
HRYZ Biotech Co.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)